Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹636.10
6.45 (1.02%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹1.27K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
14.3
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹440+44.6%
52W High₹770-17.4%
Current Price
₹636.10
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹508.88
Upper Circuit₹763.32
Reference Price
₹636.10
Investment Checklist
Triple Bottom on 1W (BREAKOUT CONFIRMED) — target ₹730.8
Double Bottom on 1W (BREAKOUT CONFIRMED) — target ₹716.7
Volume divergence: Bearish (price up, volume down)
EMA(9) Crossover: Price crossed above EMA(9): Fresh bullish momentum signal.
SuperTrend(10,3): Price below SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
44%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition | Bullish MA stack (20>50>200)
EMA20
646
EMA50
638.11
EMA200
583.09
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows5
Lower Highs5
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹651.45
₹659.00
₹677.00
₹724.95
₹733.00
Support (Below)
₹634.50
₹616.62
₹598.60
₹583.35
₹562.69
Volume Analysis
TrendDECREASING
Change-34.50%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹629.74
3% Risk₹617.02
5% Risk₹604.29
7% Risk (Custom)
₹591.57Technical Levels
1x ATR (Volatility)₹603.84
2x ATR (Swing)₹571.58
3x ATR (Trend)₹539.32
Immediate Support₹634.50
Moving Averages
EMA 9 (Short-term)₹634.95
EMA 200 (Long-term)₹583.09
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Sep '25 |
|---|---|---|---|---|
| Revenue | ₹146.6 Cr | ₹160.2 Cr | ₹154.1 Cr | ₹163.4 Cr |
| Net Profit | ₹20.8 Cr | ₹11.6 Cr | ₹27.7 Cr | ₹20 Cr |
| EPS | ₹10.37 | — | ₹13.82 | ₹9.98 |
| Operating Profit | ₹32.6 Cr | ₹19.8 Cr | ₹39.1 Cr | ₹32.7 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 12 Sept 2025 | Dividend - Rs 1.80 Per Share | DIVIDEND |
| 13 Sept 2024 | Dividend - Rs 1.80 Per Share | DIVIDEND |
| 15 Sept 2023 | Annual General Meeting/Dividend - Rs 1.50 Per Share | AGM |
| 15 Sept 2022 | Annual General Meeting/Dividend - Rs 1.50 Per Share | AGM |
| 16 Sept 2021 | Dividend - Rs 1.50 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for LINCOLN
View All
neutral
Google News - Investing.com India 15h ago
Lincoln National options trading jumps to 2,601 contracts By Investing.com - Investing.com India
Lincoln National options trading jumps to 2,601 contracts By Investing.comInvesting.com India
LINCOLNHealthcare
NEWS
negative
Business Standard - Markets 15d ago
Jaykay Enterprises Ltd leads losers in 'B' group
Lincoln Pharmaceuticals Ltd, Rajdarshan Industries Ltd, Tolins Tyres Ltd and Raj Television Network Ltd are among the other losers in the BSE's 'B' group today, 29 May 2026.
ARENTERPBSEJAYKAYLINCOLNRAJTVTOLINSTVTODAYAutomobile and Auto ComponentsCapital Goods
positive
ET Markets - Industry 15d ago
Lincoln Pharmaceuticals posts Rs 11.63 crore profit for Q4
Lincoln Pharmaceuticals announced a slight profit rise for the fourth quarter ending March 31, 2026. Full fiscal year 2025-26 saw over 6 percent growth in consolidated net profit. Revenue from operations also increased year-on-year. The company's board recommended an 18 percent dividend. Lincoln Pharmaceuticals targets Rs 1,000 crore revenue in three years.
DIVIDENDLINCOLNMOGSECFinancial ServicesHealthcare